VZL 2005, 74(1):9-14

Haematopoetic Stem Cell Transplantation and Quality of Life

Ladislav Slováček1,2, Birgita Slováčková1,2, Ladislav Jebavý3, Martin Blažek2
1 Univerzita obrany, katedra válečného vnitřního lékařství Fakulty vojenského zdravotnictví v Hradci Králové
2 Oddělení klinické hematologie II. interní kliniky Fakultní nemocnice, Hradec Králové
3 Psychiatrická klinika Fakultní nemocnice, Hradec Králové

Transplantace krvetvorných buněk je moderní léčebnou metodou užívanou nejen v léčbě hematologických malignit, ale i v léčbě solidních tumorů a v neposlední řadě i v léčbě nenádorových onemocnění. Podobně jako jiné léčebné metody ovlivňuje transplantace krvetvorných buněk další průběh onemocnění a tím i kvalitu života nemocného. Autoři popisují možnosti hodnocení kvality života nemocných po transplantaci krvetvorných buněk.

Keywords: Transplantace krvetvorných buněk; Kvalita života; Dotazníky kvality života

The haematopoetic stem cell transplantation is a modern therapeutic method which is not only used for the treatment of haematooncological diseases but also as a therapy for the solid tumors and the non-malignant diseases. The haematopoetic stem cell transplantation influences the further course of the disease and by this, the quality of life for patients in the same way as other therapeutic methods. The authors described the evaluation possibilities for the quality of life in patients who have undergone the haematopoetic stem cell transplantation.

Keywords: Haematopoetic stem cell transplantation; Quality of life; Quality of life questionnaire

Received: June 4, 2004; Published: March 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slováček, L., Slováčková, B., Jebavý, L., & Blažek, M. (2005). Haematopoetic Stem Cell Transplantation and Quality of Life. Vojenské Zdravotnické Listy, 74(1), 9-14
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ANDĚL, M., et al. Vnitřní lékařství. Díl IIIb - hematologie. Praha, Galén, 2001.
    2. ANDRYKOWSKI, MA., et al. Quality of life following bone marrow transplantation: finding from a multicentre study. Dr. J. Cancer, 1995, vol. 71, no. 6, p. 1322-1329. Go to original source... Go to PubMed...
    3. BAKER, F., et al. Reintegration after bone marrow transplantation. Cancer Pract., 1999, vol. 7, no. 4, p. 190-197. Go to original source... Go to PubMed...
    4. BRYCHTA, M. - HNILICA, K. Vliv únavy na kvalitu života onkologických pacientů. Klin. Onkol., 2004, roč. 17, no. 1, s. 18-24.
    5. BUSH, NE., et al. Conditional and Unconditional Estimation of Multidimensional Quality Quality of Life After Hematopoetic Stem Cell Transplantation: A Longitudinal Follow-up of 415 Pacients. Biology of Blood and Marrow Transplantation, 2000, vol. 6, p. 576-591. Go to original source... Go to PubMed...
    6. BYAR, KL. - NUSS, S. Self-reported quality of life post-autologous transplant for Hodgkins and non-Hodgkins lymphoma (HD and NHL). http://www.ons.org/xp6/ONS/Convention.xml/Abstracts.xml/Abstracts_2001
    7. CARLSON, LE. - MACRAE, JH. Quality of life issues fol-lowing autologous bone marrow transplantation. www.future -drugs.com.
    8. DANCEY, J., et al. Quality of life (QOL) analysis of a randomized trial of high-dose chemotherapy (HDCT) with peripherial stem cell transplant (PSCT) versus standard chemotherapy (SCT) in women with metastatic breast cancer (MBC): National Cancer Institute of Canada Clinical Trials Group study (NCIC CTG) MA-16. 2002.
    9. DURAES, MIC. Influencia da fonte de célula (progenitora periférica ou medula óssea) na qualidada de vida de pacientes onco-hematológicos submetidos ao transplante alogenico de medula óssea. Rev. Bras. Haematol. Hemoter., 2002, vol. 24, no. 1, p. 63-64. Go to original source...
    10. DE SOUZA, CA., et al. Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft. Haematologica, 2002, vol. 87, no. 12, p. 1281-1285. Go to PubMed...
    11. GODDER, KT. - HENSLEE-DOWNEY, PJ. Colony-stimulating factors in stem cell transplantation: effect on quality of life. J. Hematother Stem Cell Res., 2001, vol. 10, no. 2, p. 215-228. Go to original source... Go to PubMed...
    12. GREINER, W. - SCHULENBURG, J. - GRAF, M. Ansatze der Lebensqualitatsmessung bei Leber und Nierentransplantationsempfangern. Transplantationsmedizin, ökonomische, ethische, rechtliche und medizinsche Aspekte. Baden-Baden (German), 1995, Suppl., S. 79-114.
    13. HACKER, ED. Quantitative measurement of quality of life in adult patients undergoing bone marrow transplantation or peripheral blood stem cell transplantation: a decade in review. Oncol. Nurs Forum, 2003, vol. 30, vol. 4, p. 613-629. Go to original source... Go to PubMed...
    14. HEINONEN, H., et al. Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant, 2001, vol. 28, no. 5, p. 503-509. Go to original source... Go to PubMed...
    15. HEINONEN, H., et al. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann. Hematol., 2001, vol. 80, no. 3, p. 137-143. Go to original source... Go to PubMed...
    16. IISU, C., et al. Survival-weighted healt profile for long-term survivors of acute myelogenous leukemia. Qual Life Res 2003, 12 (5): pp. 503-17 Go to original source... Go to PubMed...
    17. KISS, TL., et al. Long-term medical outcomes and quality of life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J. Clin. Oncol., 2002, vol. 20, no. 9, p. 2334-2343. Go to original source... Go to PubMed...
    18. KLENER, P., aj. Klinická onkologie. Praha, Galén, 2002. 726 s.
    19. KLENER, P., aj. Vnitřní lékařství - díl II. Praha, Karolinum, 1995.
    20. LEE, SJ., et al. Development and Validation of scale to Measure Symptoms of Chronic Graft-versus-Host Disease. Biol. Blood Marrow Transplant., 2002, vol. 8, no. 8, p. 444-452. Go to original source... Go to PubMed...
    21. McGUIRE, DB., et al. The 20 item oral mucositis index: reliability and validity in bobe marrow and stem cell transplant patients. Cancer Invest., 2002, vol. 20, no. 7/8, p. 893-903. Go to original source... Go to PubMed...
    22. MOUNIER, N., et al. Quality of life adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Étude les Lymphomes de l'Ádult (GELA). Blood, 2000, vol. 95, no. 12, p. 3687-3692.
    23. NORUM, J., et al. Treatment costs in Hodgkins disease: a cost-utility analysis. Eur. J. Cancer, 1996, vol. 32A, no. 9, p. 1510-1517. Go to original source... Go to PubMed...
    24. SIGMAN, HD. - GRADY, PA. Quality of life for transplantation patients: National Institute of Nursing Research Spring Science Work Group. Heart and Lung, 2001, vol. 30, no. 1, p. 5-8. Go to original source... Go to PubMed...
    25. SO, WK. - DODGSON, J. - TAI, JW. Fatigue and quality of life among Chinese patients with hematologic malignancy and bone marrow transplantation. Cancer Nurs, 2003, vol. 26, no. 3, p. 211-219. Go to original source... Go to PubMed...
    26. UYL-DE GROOT, CA., et al. Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate and high-grade malignant non-Hodgkins lymphoma (NHL). Bone Marrow Transplant., 1995, vol. 16, no. 8, p. 463-470. Go to PubMed...
    27. VAN AGTHOVEN, M., et al. Cost analysis and quality of life assessment comparing undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkins lymphoma or Hodgkins disease, a prospective randomised trial. Eur. J. Cancer, 2001, vol. 37, no. 14, p. 1781-1789. Go to original source... Go to PubMed...
    28. VELLENGA, E., et al. Randomised placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. J. Clin. Oncol., 1996, vol. 14, no. 2, p. 619-627. Go to original source... Go to PubMed...
    29. WANG, WQ. - LIN, GW. Study on quality of life in long-term survivors with acute leukemia in Shanghay. Zhonghua Liu Xing Bing Xue Za Zhi, 2003, vol. 24, no. 11, p. 1049-1051. Go to PubMed...
    30. WONG, R., et al. Reduced-intensity conditioning for unrelated donor hematopoetic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood, 2003, vol. 102, no. 8, p. 3052-3059. Go to original source... Go to PubMed...
    31. YU, CLM., et al. Measuring Quality of Life of Chinese Cancer Patients: A Validation of the Chinese Version of the Functional Assessment of Cancer Therapy-General (FACT-G) Scale. Cancer, 2000, vol. 88, no. 7, p. 1715-1727. Go to original source...

    Return to the content